In-Ho Chae Selected Research

Serotonin (5 Hydroxytryptamine)

3/2016	Efficacy and Safety of DP-R202 in Patients with Chronic Artery Occlusive Disease: Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Clinical Study.
7/2015	Study design of the influence of SErotonin inhibition on patients with RENAl impairment or diabetes undergoing drug-eluting stent implantation (SERENADE) study: A multicenter, open-label, prospective, randomized study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

In-Ho Chae Research Topics

Disease

48	Myocardial Infarction 04/2024 - 06/2004
34	Thrombosis (Thrombus) 04/2024 - 01/2008
24	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 06/2004
23	Coronary Artery Disease (Coronary Atherosclerosis) 02/2023 - 01/2002
15	ST Elevation Myocardial Infarction 06/2022 - 06/2007
13	Death (Near-Death Experience) 05/2022 - 06/2010
12	Diabetes Mellitus 01/2020 - 01/2003
11	Pathologic Constriction (Stenosis) 01/2022 - 02/2002
10	Acute Coronary Syndrome 04/2024 - 03/2012
10	Coronary Stenosis (Coronary Artery Stenosis) 01/2016 - 08/2009
9	Hemorrhage 02/2023 - 09/2008
7	Stroke (Strokes) 01/2023 - 04/2008
7	Infarction (Infarctions) 01/2022 - 10/2006
6	Hypertension (High Blood Pressure) 03/2023 - 05/2009
6	Ischemia 01/2023 - 07/2007
6	Peripheral Arterial Disease 01/2023 - 03/2016
6	Coronary Disease (Coronary Heart Disease) 10/2020 - 01/2009
6	Hyperplasia 07/2019 - 08/2003
5	Heart Failure 08/2017 - 08/2008
4	Reperfusion Injury 07/2023 - 09/2011
4	Dyslipidemias (Dyslipidemia) 03/2023 - 01/2017
4	Myocardial Ischemia (Ischemic Heart Diseases) 05/2022 - 06/2008
4	Hypercholesterolemia 01/2021 - 10/2016
4	Renal Insufficiency (Renal Failure) 07/2011 - 09/2006
3	Atrial Fibrillation 07/2023 - 01/2019
3	Ischemic Stroke 02/2023 - 08/2010
3	Chronic Renal Insufficiency 01/2018 - 03/2008
3	Atherosclerosis 05/2016 - 11/2012
3	Inflammation (Inflammations) 09/2015 - 12/2003
3	Neointima 08/2007 - 08/2003
2	Atherosclerotic Plaque (Atheroma) 10/2023 - 09/2011
2	Aortic Valve Stenosis (Aortic Stenosis) 07/2023 - 01/2023
2	Pain (Aches) 01/2022 - 06/2007
2	Unstable Angina 08/2021 - 02/2013
2	Essential Hypertension 01/2018 - 05/2009
2	Vascular Remodeling 07/2016 - 08/2013
2	Vascular Diseases (Vascular Disease) 01/2016 - 05/2009
2	Chest Pain (Chest Pains) 02/2012 - 06/2011
2	Hyperemia 09/2011 - 08/2005
1	Rupture 04/2024
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 04/2024
1	Vascular System Injuries 11/2023
1	Dementia (Dementias) 10/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2022
1	Chronic Limb-Threatening Ischemia 06/2022

Drug/Important Bio-Agent (IBA)

12	omega-Chloroacetophenone (Mace)IBA 05/2022 - 06/2004
11	LipidsIBA 04/2024 - 01/2009
10	Sirolimus (Rapamycin)FDA Link 01/2020 - 01/2009
9	Clopidogrel (Plavix)FDA Link 01/2023 - 09/2008
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2021 - 08/2010
7	Rosuvastatin Calcium (Crestor)FDA Link 09/2023 - 10/2016
7	Cilostazol (Pletal)FDA LinkGeneric 01/2023 - 01/2008
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2023 - 09/2008
5	Ezetimibe (Zetia)FDA Link 09/2023 - 10/2016
5	Prasugrel Hydrochloride FDA Link 02/2023 - 09/2015
5	MetalsIBA 07/2019 - 01/2008
5	Biomarkers (Surrogate Marker)IBA 03/2013 - 10/2007
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 07/2021 - 01/2011
4	Everolimus FDA Link 06/2020 - 08/2013
4	Paclitaxel (Taxol)FDA LinkGeneric 08/2011 - 08/2007
3	PolymersIBA 01/2021 - 09/2015
3	oxidized low density lipoproteinIBA 10/2020 - 08/2012
3	CholesterolIBA 07/2020 - 01/2009
3	Erythropoietin FDA Link 03/2019 - 06/2011
3	Glucose (Dextrose)FDA LinkGeneric 11/2018 - 01/2003
3	Celecoxib (Celebrex)FDA Link 11/2012 - 08/2007
2	Chelating AgentsIBA 07/2023 - 01/2022
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2023 - 01/2012
2	BESIBA 01/2023 - 09/2015
2	Adenosine Triphosphate (ATP)IBA 06/2022 - 10/2016
2	Antihypertensive Agents (Antihypertensives)IBA 09/2021 - 01/2020
2	LDL CholesterolIBA 10/2020 - 08/2012
2	telmisartan amlodipine combination FDA Link 10/2020 - 01/2018
2	EnzymesIBA 03/2019 - 06/2011
2	CalciumIBA 12/2016 - 02/2012
2	cadherin 5IBA 07/2016 - 09/2011
2	Serotonin (5 Hydroxytryptamine)IBA 03/2016 - 07/2015
2	sarpogrelateIBA 03/2016 - 07/2015
2	Dobutamine FDA LinkGeneric 01/2016 - 09/2011
2	Heparin (Liquaemin)FDA LinkGeneric 01/2015 - 06/2007
2	Glycoproteins (Glycoprotein)IBA 01/2015 - 12/2012
2	zotarolimusIBA 07/2014 - 10/2012
2	CytokinesIBA 01/2012 - 01/2011
2	Adenosine (Adenocard)FDA LinkGeneric 09/2011 - 08/2005
2	iodixanol (Visipaque)FDA Link 07/2011 - 09/2006
2	Acetylcysteine (Siran)FDA LinkGeneric 07/2011 - 03/2009
2	AlbuminsIBA 08/2010 - 12/2003
2	CreatinineIBA 08/2010 - 03/2008
1	Telmisartan (Micardis)FDA Link 03/2023
1	tyrosine-4-azophenyltrimethylammonium chloride (TAPT)IBA 01/2023

Therapy/Procedure

54	Stents 11/2023 - 08/2005
31	Percutaneous Coronary Intervention 04/2024 - 01/2002
28	Therapeutics 04/2024 - 06/2007
28	Drug-Eluting Stents 01/2023 - 01/2008
6	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020 - 04/2008
3	Surgical Amputation (Amputations) 01/2023 - 01/2019
2	Transcatheter Aortic Valve Replacement 07/2023 - 01/2023
2	Length of Stay 08/2008 - 08/2008
1	Toothbrushing 01/2024
1	Drug Tapering 04/2022